Halberd Co. (OTCMKTS:HALB) Short Interest Update

Halberd Co. (OTCMKTS:HALB) saw a large decline in short interest in January. As of January 15th, there was short interest totalling 700 shares, a decline of 96.9% from the December 31st total of 22,300 shares. Based on an average trading volume of 1,645,800 shares, the days-to-cover ratio is currently 0.0 days.

Halberd Stock Down 3.1 %

Shares of HALB opened at $0.00 on Wednesday. Halberd has a 52 week low of $0.00 and a 52 week high of $0.01.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.